Mounjaro Costs: Pricing Drivers, Coverage and Protocols

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

You are reading this inside the PlexusDx Education Hub, where we unpack GLP-1 therapies, weight-management protocols, and the inherited biology that colors each of those choices. Browse the full Peptides & GLP-1 library.

Mounjaro (tirzepatide) is among the most-searched GLP-1 medications in the U.S. as of April 2026, and cost questions cluster tightly around it: what it lists at, why that number is high, and what genuinely moves it. This page reports the published price, the coverage and savings factors, the compounding context, and how PlexusDx structures its own protocols — all as published, and all as context rather than a quote.

What Mounjaro lists at

Mounjaro carries a U.S. list price of roughly $1,069 per month as of April 2026, per Eli Lilly’s published pricing. Out-of-pocket cost swings around that number based on coverage, the indication on the prescription, manufacturer savings programs, and the pharmacy where it is filled. List price is rarely what an insured patient actually pays.

Why the price sits where it does

Mounjaro is a patent-protected branded medication, and Eli Lilly sets its list price around research-and-development cost recovery, market positioning, and expected payer mix. Prices have stayed high in part because demand outpaced manufacturing during 2023–2024. Savings programs and compounded alternatives are the levers patients most often use against that.

Insurance and coverage notes

Coverage depends on whether the prescription is for an FDA-approved indication and on the plan’s formulary. Many commercial plans cover tirzepatide for type 2 diabetes; chronic weight-management coverage is more variable and often subject to prior authorization or BMI-based criteria. Check with your plan directly as of April 2026.

Savings programs and discounts

Eli Lilly publishes a manufacturer savings card that can substantially reduce monthly cost for eligible commercially-insured patients. Independent pharmacy platforms such as GoodRx and SingleCare publish coupon prices that vary by pharmacy. Eligibility and amounts shift over time, so verify at the manufacturer site or your pharmacy at the time of fill.

Compounded alternatives and shortage context

Between 2022 and 2024, the FDA listed tirzepatide on its drug shortage list, opening a pathway for licensed 503A pharmacies to compound it. The agency resolved the tirzepatide shortage in 2024, narrowing but not eliminating that route. Legitimate compounded protocols, when prescribed by a licensed clinician through a state-licensed pharmacy, remain a real option, with pricing and access that vary.

How PlexusDx structures its protocols

PlexusDx offers clinician-supervised compounded GLP-1 protocols inside its Weight Management Protocols — including Tirzepatide Injection, Tirzepatide Oral, Microdose GLP-1, and GLP-Squared — each with current pricing on its own product page. Upstream of any protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, reading variants such as FTO, and MC4R that shape baseline appetite and energy balance. It never predicts response to any medication; it is the test-before-you-invest context PlexusDx brings to every conversation.

What actually moves the number

Stepping back, only a handful of levers meaningfully change what a patient pays: whether the indication is covered, whether a savings card or coupon applies, and whether a compounded route is appropriate. The list price sets the ceiling, but these levers determine where within that ceiling a given person lands.

Matching the protocol to the person

Cost is only one input. The right protocol also depends on the individual’s goals, tolerability, and clinical picture, which is why PlexusDx frames pricing as one part of a broader, provider-guided decision rather than the whole of it. Looking at the biology and the budget together, instead of treating price in isolation, tends to produce a choice a patient can actually stay with over time. A protocol that fits the budget but not the person is easy to abandon, while one matched to both goals and tolerability stands a better chance of lasting, which is ultimately what makes the spending worthwhile. Framing the whole question around fit, rather than price alone, is what turns a one-time purchase into a plan someone can actually follow.

Frequently Asked Questions

Why is Mounjaro so expensive?

It is a patent-protected branded medication, and Eli Lilly sets its list price around R&D cost recovery, market positioning, and expected payer mix. Prices have stayed high partly because demand outpaced manufacturing during 2023–2024. Savings programs and compounded alternatives are the main levers patients use against that.

Is there a savings card for Mounjaro?

Yes. Eli Lilly publishes a manufacturer savings card that can substantially reduce monthly cost for eligible commercially-insured patients. Independent coupons from GoodRx and SingleCare also publish discounted prices that vary by pharmacy and change often. Verify eligibility and current terms at the time of fill.

Are compounded versions cheaper?

Often, compounded tirzepatide from licensed 503A pharmacies has been priced below Mounjaro’s list price. The trade-offs are regulatory complexity, variability in prescriber oversight, and the FDA’s evolving stance after the 2024 shortage resolution. Discuss suitability with a qualified clinician before choosing this route.

Does the genetic test change my cost?

No. The Precision Peptide Genetic Test never predicts drug response or discounts a prescription. It analyzes pathway-level variants such as FTO, and MC4R to provide upstream metabolic context — a test-before-you-invest step for your provider conversation, separate from what any protocol costs.

Keep exploring the rest of the collection in the PlexusDx Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.